![Treatment of Schamberg`s disease with pentoxifylline](http://s1.studyres.com/store/data/007827749_1-d7e998c92d8e5604e4c0311a552245ff-300x300.png)
Treatment of Schamberg`s disease with pentoxifylline
... have demonstrated a decrease in expression of ICAM-I on endothelial cells of blood vessels of lesional skin following successful treatment with pentoxifylline. This results in decreased exudation of inflammatory cells from capillaries into the surrounding perivascular tissue. Moreover, pentoxifyllin ...
... have demonstrated a decrease in expression of ICAM-I on endothelial cells of blood vessels of lesional skin following successful treatment with pentoxifylline. This results in decreased exudation of inflammatory cells from capillaries into the surrounding perivascular tissue. Moreover, pentoxifyllin ...
Treatment of Recalcitrant Lichen Planus with Low Molecular Weight
... Lichen planus (LP) is a unique, common, pruritic, inflammatory disease of the skin, mucous membranes and hair follicles. The exact pathogenesis of LP is unknown, but it is evident that immunologic mechanisms almost certainly mediate the development of LP. Cell mediated immunity plays the major role ...
... Lichen planus (LP) is a unique, common, pruritic, inflammatory disease of the skin, mucous membranes and hair follicles. The exact pathogenesis of LP is unknown, but it is evident that immunologic mechanisms almost certainly mediate the development of LP. Cell mediated immunity plays the major role ...
Case 2 - Weill Cornell Dermatopathology Service
... are attributable to phagocytosis of hematopoeitic elements by macrophages which in turn are activated by the neoplastic T cells. The clonal T cells apparently induce the production of macrophage activating factor. It is interesting to note that while this patient did not have any cytopenias she sust ...
... are attributable to phagocytosis of hematopoeitic elements by macrophages which in turn are activated by the neoplastic T cells. The clonal T cells apparently induce the production of macrophage activating factor. It is interesting to note that while this patient did not have any cytopenias she sust ...
THERAPEUTIC UPDATE New Products
... Statistically, the combination product was more effective than the steroid alone, but clinically the benefit was questionable. The new review included 59 randomized controlled trials with a total of 11,561 participants. Thirty studies were either conducted or sponsored by the manufacturer of the stu ...
... Statistically, the combination product was more effective than the steroid alone, but clinically the benefit was questionable. The new review included 59 randomized controlled trials with a total of 11,561 participants. Thirty studies were either conducted or sponsored by the manufacturer of the stu ...
the Press Release
... Targeted melanoma therapy A fine-tuned network of signalling molecules tells cells how to grow in a healthy environment. Publicly funded academic research uncovered aberrant signalling events that are capable of driving benign pigment cells to become melanomas. These academic findings now allowed de ...
... Targeted melanoma therapy A fine-tuned network of signalling molecules tells cells how to grow in a healthy environment. Publicly funded academic research uncovered aberrant signalling events that are capable of driving benign pigment cells to become melanomas. These academic findings now allowed de ...
TREATMENT PATHWAY FOR ACTINIC (SOLAR) KERATOSIS RED
... 1. All topical treatments cause inflammation which indicates their desired action against abnormal cells. If severe then the treatments should be stopped until the reaction subsides and then restarted, perhaps at a reduced frequency. Patients should be warned to expect this effect of the treatment r ...
... 1. All topical treatments cause inflammation which indicates their desired action against abnormal cells. If severe then the treatments should be stopped until the reaction subsides and then restarted, perhaps at a reduced frequency. Patients should be warned to expect this effect of the treatment r ...
Chondrodermatitis Nodularis Helicis Successfully
... part of the more nodular lesions. Then methyl aminolevulinate, 16% (Metvix; Galderma, Sophia Antipolis, France), was applied on and 1 cm around the lesions and under the occlusive dressing (Tegaderm; 3M Healthcare, St Paul, Minnesota) and then covered with aluminum foil for 3 hours. Fluorescence was ...
... part of the more nodular lesions. Then methyl aminolevulinate, 16% (Metvix; Galderma, Sophia Antipolis, France), was applied on and 1 cm around the lesions and under the occlusive dressing (Tegaderm; 3M Healthcare, St Paul, Minnesota) and then covered with aluminum foil for 3 hours. Fluorescence was ...
Excimer Laser for Psoriasis: An Update on Treatment
... Having used traditional light boxes in my practice for many years, I was somewhat skeptical about using excimer laser therapy for psoriasis. However, over time I have been convinced of the benefit and now have three lasers, one in each of my offices. I have made changes to my practice to accommodate ...
... Having used traditional light boxes in my practice for many years, I was somewhat skeptical about using excimer laser therapy for psoriasis. However, over time I have been convinced of the benefit and now have three lasers, one in each of my offices. I have made changes to my practice to accommodate ...
Rezakhani Soheila Alterations of Liver Function Tests in 134 Lichen
... Background: Lichen planus (LP) is an inflammatory mucocutaneous disease with unknown ethiology that cutaneous lesions describe as flat-topped, shiny, polyangular, purlish and pruritus papuls and plaques involving the flexors surfaces, mucous membranes and genitalia. LP has a worldwide distribution a ...
... Background: Lichen planus (LP) is an inflammatory mucocutaneous disease with unknown ethiology that cutaneous lesions describe as flat-topped, shiny, polyangular, purlish and pruritus papuls and plaques involving the flexors surfaces, mucous membranes and genitalia. LP has a worldwide distribution a ...
28-05-12 ALLERGY: • SURVEILLANCE OF CONTACT ALLERGIES
... Although this study provides evidence of an ‘add-on’ macrolide treatment on acute asthma exacerbations, it does not propose such an intervention as a clinical guidance. Several issues have still to be solved in respect to clearly define populations who might benefit from such intervention, elucidate ...
... Although this study provides evidence of an ‘add-on’ macrolide treatment on acute asthma exacerbations, it does not propose such an intervention as a clinical guidance. Several issues have still to be solved in respect to clearly define populations who might benefit from such intervention, elucidate ...
Diagnostic Microscopic Features of Cutaneous Leishmaniasis other
... excluded. Skin biopsies were taken, stained with hematoxyline & eosin stain (H & E stain) and studied in collaboration with dermatopathologist. Different histopathological findings were recorded and results analyzed. Results: Leishmania Tropica Bodies were found in (43 %) of patients. Other histolog ...
... excluded. Skin biopsies were taken, stained with hematoxyline & eosin stain (H & E stain) and studied in collaboration with dermatopathologist. Different histopathological findings were recorded and results analyzed. Results: Leishmania Tropica Bodies were found in (43 %) of patients. Other histolog ...
Hairy cell leukemia
![](https://commons.wikimedia.org/wiki/Special:FilePath/Hairy_cell_leukemia.jpg?width=300)
Hairy cell leukemia is an uncommon hematological malignancy characterized by an accumulation of abnormal B lymphocytes. It is usually classified as a sub-type of chronic lymphoid leukemia. Hairy cell leukemia makes up approximately 2% of all leukemias, with fewer than 2,000 new cases diagnosed annually in North America and Western Europe combined.Hairy cell leukemia was originally described as histiocytic leukemia, malignant reticulosis, or lymphoid myelofibrosis in publications dating back to the 1920s. The disease was formally named leukemic reticuloendotheliosis and its characterization significantly advanced by Bertha Bouroncle and colleagues at The Ohio State University College of Medicine in 1958. Its common name, which was coined in 1966, is derived from the ""hairy"" appearance of the malignant B cells under a microscope.